BOT vs ICR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BOT

BOTANIX FPO [BOT]

39LOW

ICR

INTELICARE FPO [ICR]

36LOW

Score Breakdown

BOT ICR
Technical
47
51
Catalyst
51
50
Sentiment
50
50
Fundamental
76
27
Momentum
29
46
Risk Gate
45
42

Key Metrics

BOT Metric ICR
$70.7MMarket Cap$13.0M
14.5MAvg Volume (20d)334K
+0.2%Short InterestN/A
$0.18052-Week High$0.035
$0.01852-Week Low$0.012
+0.0%Daily Change+0.0%
$0.025Reference Price$0.021
-121.1%ROE-1420.4%
N/AProfit MarginN/A

Active Signals

BOT Signals

●Stochastic is stretched into overbought — could need a breather
●Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (3.2x)
●Strong revenue growth (+4271%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)

ICR Signals

●MACD momentum is picking up steam
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Moderate P/S ratio (13.8x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Micro-cap ($5-20M) - high risk
●Capital raise activity (1 events)
●Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare BOT and ICR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BOT vs ILA →BOT vs LGP →BOT vs OSL →BOT vs PGC →BOT vs RAD →
BOT Full Analysis → ICR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).